APA (7th ed.) Citation

Delino, N. S. (2018). GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants [Antiviral Agents]. The American Society for Microbiology (ASM).

Chicago Style (17th ed.) Citation

Delino, N. S. GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent Against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier Against the Emergence of Resistant Variants [Antiviral Agents]. The American Society for Microbiology (ASM), 2018.

MLA (9th ed.) Citation

Delino, N. S. GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent Against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier Against the Emergence of Resistant Variants [Antiviral Agents]. The American Society for Microbiology (ASM), 2018.